Chondrial Therapeutics
Bala Cynwyd
About Chondrial Therapeutics
Chondrial Therapeutics s a clinical-stage biotechnology company focused on the treatment of rare diseases. It is dedicated to the pursuit of scientific research leading to the treatment for Friedreich’s Ataxia and other mitochondrial diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $49.4M
- Funding stage: M&A
- Last round: Series B (May 2019)
- Website: chondrialtherapeutics.com
- Phone: 317-370-2234
Industries & Categories
Biotechnology, Health Care, Therapeutics
Canonical: https://fsome.com/organization/chondrial-therapeutics-46065 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.